Yogalingam, Gouri

Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis

Yogalingam, G., Bonten, E. J., van de Vlekkert, D., Hu, H., Moshiach, S., Connell, S. A., & d'Azzo, A. (2008) · Developmental Cell

Cellular transport and secretionGlycosylation and Glycoproteins Research

Cited by 185

Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis

Bonten, E. J., Wang, D., Toy, J. N., Mann, L., Mignardot, A., Yogalingam, G., & d'Azzo, A. (2004) · The FASEB Journal

Lysosomal Storage Disorders ResearchViral Infectious Diseases and Gene Expression in Insects

Cited by 54

Short-term, high dose enzyme replacement therapy in sialidosis mice

Wang, D., Bonten, E. J., Yogalingam, G., Mann, L., & d’Azzo, A. (2005) · Molecular Genetics and Metabolism

Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus

Cited by 50

Identifying therapeutic drug targets using bidirectional effect genes

Estrada, K., Froelich, S., Wuster, A., Bauer, C. R., Sterling, T., Clark, W. T., Ru, Y., Trinidad, M., Nguyen, H. P., Luu, A. R., et al. (2021) · Nature Communications

Genomics and Rare DiseasesGenetic Associations and Epidemiology

Cited by 25

Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency

Luu, A. R., Wong, C., Agrawal, V., Wise, N., Handyside, B., Lo, M. J., Pacheco, G., Felix, J. B., Giaramita, A., d'Azzo, A., et al. (2020) · Journal of Biological Chemistry

Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus

Cited by 14